This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 104/9/1066    most recent CIRCRESAHA.109.196691v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Wang, D. Articles by Rao, G. N. Search for Related Content PubMed PubMed Citation Articles by Wang, D. Articles by Rao, G. N. Related Collections Restenosis Cell signalling/signal transduction Smooth muscle proliferation and differentiation Mechanism of atherosclerosis/growth factors

(Circulation Research. 2009;104:1066.)
© 2009 American Heart Association, Inc.

Molecular Medicine

A Role for Gab1/SHP2 in Thrombin Activation of PAK1

Gene Transfer of Kinase-Dead PAK1 Inhibits Injury-Induced Restenosis

Dong Wang, Biman C. Paria, Qiuhua Zhang, Manjula Karpurapu, Quanyi Li, William T. Gerthoffer, Yoshikazu Nakaoka, Gadiparthi N. Rao

From the Department of Physiology (D.W., B.C.P., Q.Z., M.K., Q.L., G.N.R.), University of Tennessee Health Science Center, Memphis; Department of Biochemistry & Molecular Biology (W.T.G.), University of South Alabama College of Medicine, Mobile; and Department of Cardiovascular Medicine (Y.N.), Osaka University Graduate School of Medicine, Japan.

Correspondence to Gadiparthi N. Rao, PhD, Department of Physiology, University of Tennessee Health Science Center, 894 Union Ave, Memphis, TN 38163. E-mail grao{at}physio1.utmem.edu

To understand the role of epidermal growth factor receptor (EGFR) transactivation in G protein-coupled receptor (GPCR) agonist-induced signaling events, we have studied the capacity of thrombin in the activation of Gab1-SHP2 in vascular smooth muscle cells (VSMCs). Thrombin activated both Gab1 and SHP2 in EGFR-dependent manner. Similarly, thrombin induced Rac1 and Cdc42 activation, and these responses were suppressed when either Gab1 or SHP2 stimulation is blocked. Thrombin also induced PAK1 activation in a time- and EGFR-Gab1-SHP2-Rac1/Cdc42-dependent manner. Inhibition of activation of EGFR, Gab1, SHP2, Rac1, Cdc42, or PAK1 by pharmacological or genetic approaches attenuated thrombin-induced VSMC stress fiber formation and motility. Thrombin activated RhoA in a time-dependent manner in VSMCs. LARG, a RhoA-specific GEF (guanine nucleotide exchange factor), was found to be associated with Gab1 and siRNA-mediated depletion of its levels suppressed RhoA, Rac1 and PAK1 activation. Dominant negative mutant-mediated interference of RhoA activation inhibited thrombin-induced Rac1 and PAK1 stimulation in VSMCs and their stress fiber formation and migration. Balloon injury induced PAK1 activity and interference with its activation led to attenuation of SMC migration from media to intima, resulting in reduced neointima formation and increased lumen size. Inhibition of thrombin signaling by recombinant hirudin also blocked balloon injury-induced EGFR tyrosine phosphorylation and PAK1 activity. These results show that thrombin-mediated PAK1 activation plays a crucial role in vascular wall remodeling and it could be a potential target for drug development against these vascular lesions.

Key Words: RhoGEF • GTPases • PAK1 • neointima